Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Express Scripts
Daiichi Sankyo
Harvard Business School

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,470,567

« Back to Dashboard

Summary for Patent: 5,470,567

Title: Synergistic skin depigmentation composition
Abstract:There is disclosed a synergistic composition and process for skin depigmentation with reduced irritation which does not employ a corticosteroid and which employs a substituted oxybenzene and a retinoid.
Inventor(s): Nair; Xina (E. Amherst, NY), Tramposch; Kenneth M. (Williamsville, NY)
Assignee: Bristol Myers Squibb Company (New York, NY)
Application Number:08/141,503
Patent Claim Types:
see list of patent claims
Composition; Use;

No matches for this query

International Patent Family for Patent: 5,470,567

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria104544► Subscribe
Brazil1100177► Subscribe
Canada2022917► Subscribe
Germany69008293► Subscribe
Denmark0421110► Subscribe
European Patent Office0421110► Subscribe
Spain2063217► Subscribe
Hong Kong1004888► Subscribe
Hungary211255► Subscribe
JapanH03118318► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: